[ 5 ] zur Hausen H. Oncogenic Herpes viruses[J]. Biochim Biophys Acta, 1975, 417(1): 25-53.
[2]
[ 6 ] Herrero R, Brinton LA, Reeves WC, et al. Sexual behavior, venereal diseases, hygiene practices, and invasive cervical cancer in a high-risk population[J]. Cancer, 1990, 65(2): 380-386.
[3]
[ 7 ] Matsukura T, Sugase M. Pitfalls in the epidemiologic classification of human papillomavirus types associated with cervical cancer using polymerase chain reaction: driver and passenger[J]. Int J Gynecol Cancer, 2008, 18(5): 1042-1050.
[4]
[ 8 ] Walboomers JM, Jacobs MV, Manos MM, et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide[J]. J Pathol, 1999, 189(1): 12-19.
[5]
[ 9 ] Munoz N, Bosch FX, de Sanjose S, et al. International agency for research on can-cer multicenter cervical cancer study group.epidemiologic classification of human papillomavirus types associated with cervical cancer[J]. N Engl J Med, 2003, 348(6): 518-527.
[6]
Peters WA, Liu PY, Barrett RJ, et al. Concurrent chemotherapy and pelvic radiation therapy compared with pelvic radiation therapy alone as adjuvant therapy after radical surgery in high-risk early-stage cancer of the cervix[J]. J Clin Oncol, 2000, 18(8): 1606-1613.
[7]
Thomas GM. Improved treatment for cervical cancer-concurrent chemotherapy and radiotherapy[J]. N Engl J Med, 1999, 340(15): 1198-1200.
[8]
[ 1 ] Shanta V, Krishnamurthi S, Gajalakshmi CK, et al. Epidemiology of cancer of the cervix: global and National perspective[J]. J Indian Med Assoc, 2000, 98(2): 49-52.
[ 3 ] Arbyn M, Bergeron C, Klinkhamer P, et al. Liquid compared with conventional cervical cytology: a systematic review and meta-analysis[J]. Obstet Gynecol, 2008, 111(1): 167-177.
[11]
[ 4 ] Siebers AG, Klinkhamer PJ, Grefte JM, et al. Comparison of liquid-based cytology with conventional cytology for detection of cervical cancer precursors: a randomized controlled trial[J]. JAMA, 2009, 302(16): 1757-1764.
[12]
de Sanjose S, Quint WG, Alemany L, et al. Retrospective international survey and HPV time trends study group. Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study[J]. Lancet Oncol, 2010, 11(11): 1048-1056.
[13]
Plummer M, Schiffman M, Castle PE, et al. ALTS group: a 2-year prospective study of human papillomavirus persistence among women with a cytological diagnosis of atypical squamous cells of undetermined significance or low-grade squamous intraepithelial lesion[J]. J Infect Dis, 2007, 195(11): 1582-1589.
[14]
Rodríguez AC, Schiffman M, Herrero R, et al. Rapid clearance of human papillomavirus and implications for clinical focus on persistent infections[J]. J Natl Cancer Inst, 2008, 100(7): 513-517.
[15]
Wright TC, Schiffman M. Adding a test for human papillomavirus DNA to cervical-cancer screening[J]. N Engl J Med, 2003, 348(6): 489-490.
[16]
Schiffman M, Castle PE, Jeronimo J, et al. Human papillomavirus and cervical cancer[J]. Lancet, 2007, 370(9590): 890-907.
Saslow D, Solomon D, Lawson HW, et al. American cancer society, American society for colposcopy and cervical pathology, and American society for clinical pathology screening guidelines for the prevention and early detection of cervical cancer[J]. Am J Clin Pathol, 2012, 16(3): 175-204.
[20]
Shimada M, Kigawa J, Nishimura R, et al. Ovarian metastasis in carcinoma of the uterine cervix[J]. Gynecol Oncol, 2006, 101(2): 234-237.
[21]
Nakanishi T, Wakai K, Ishikawa H, et al. A comparison of ovarian metastasis between squamous cell carcinoma and adenocarcinoma of the uterine cervix[J]. Gynecol Oncol, 2001, 82(3): 504-509.
[22]
Hu T, Wu L, Xing H, et al. Development of criteria for ovarian preservation in cervical cancer patients treated with radical surgery with or without neoadjuvant chemotherapy: a multicenter retrospective study and meta-analysis[J]. Ann Surg Oncol, 2013, 20(3): 881-890.
Koh WJ, Greer BE, Abu-Rustum NR, et al. Cervical cancer[J]. J Natl Compr Canc Netw, 2013, 11(3): 320-343.
[26]
Ribeiro Cubal AF, Ferreira Carvalho JI, Costa MF, et al. Fertility-sparing surgery for early-stage cervical cancer[J]. Int J Surg Oncol, 2012: 936534.
[27]
Klemm P, Tozzi R, K？hler C, et al. Does radical trachelectomy influence uterine blood supply[J]. Gynecol Oncol, 2005, 96(2): 283-286.
[28]
Alazzam M, Gillespie A, Hewitt M. Robotic surgery in the management of cervical carcinoma[J]. Arch Gynecol Obstet, 2011, 284(4): 937-943.
[29]
Rob L, Charvat M, Robova H, et al. Less radical fertility-sparing surgery than radical trachelectomy in early cervical cancer[J]. Int J Gynecol Cancer, 2007, 17(1): 304-310.
[30]
Milliken DA, Shepherd JH. Fertility preserving surgery for carcinoma of the cervix[J]. Curr Opin Oncol, 2008, 20(5): 575-580.
[31]
Rob L, Skapa P, Robova H. Fertility-sparing surgery in patients with cervical cancer[J]. Lancet Oncol, 2011, 12(2): 192-200.
[32]
Yabuki Y, Sasaki H, Hatakeyama N, et al. Discrepancies between classic anatomy and modern gynecologic surgery on pelvic connective tissue structure: harmonization of those concepts by collaborative cadaver dissection[J]. Am J Obstet Gynecol, 2005, 193(1): 7-15.
[33]
H？ckel M, Horn LC, Manthey N, et al. Resection of the embryologically defined uterovaginal (Müllerian) compartment and pelvic control in patients with cervical cancer: a prospective analysis[J]. Lancet Oncol, 2009, 10(7): 683-692.
Benedetti-Panici P, Greggi S, Colombo A, et al. Neoadjuvant chemotherapy and radical surgery versus exclusive radiotherapy in locally advanced squamous cell cervical cancer: results from the Italian multicenter randomized study[J]. J Clin Oncol, 2002, 20(1): 179-188.
Whitney CW, Sause W, Bundy BN, et al. Randomized comparison of fluorouracil plus cisplatin versus hydroxyurea as an adjunct to radiation therapy in stageⅡB-ⅣA carcinoma of the cervix with negative para-aortic lymph nodes: a gynecologic oncology group and southwest oncology group study[J]. J Clin Oncol, 1999, 17(5): 1339-1348.
[38]
Morris M, Eifel PJ, Lu J, et al. Pelvic radiation with concurrent chemotherapy compared with pelvic and para-aortic radiation for high-risk cervical cancer[J]. N Engl J Med, 1999, 340(15): 1137-1143.
[39]
Rose PG, Bundy BN, Watkins EB, et al. Concurrent cisplatin-based radiotherapy and chemotherapy for locally advanced cervical cancer[J]. N Engl J Med, 1999, 340(15): 1144-1153.
[40]
Keys HM, Bundy BN, Stehman FB, et al. Cisplatin, radiation, and adjuvant hysterectomy compared with radiation and adjuvant hysterectomy for bulky stage IB cervical carcinoma[J]. N Engl J Med, 1999, 340(15): 1154-1161.
